News
Regenative Labs: Case Study on Wharton’s Jelly Allografts in TMJ Defects
Oct 26, 2023
The homologous-use application validated by Dr. Ryan Robinson and NP Rachel Reynolds sets a precedent for non-surgical allograft application. Thursday,… Read More >
Regenative Labs & Brothers in Arms: $5M Partnership for Veteran Care
Sep 29, 2023
PENSACOLA, Fla. , Feb. 27, 2023 /PRNewswire/ — Regenative Labs (Regenative), a leading HCT/P manufacturer, is partnering with Brothers in Arms Foundation (BIAF), a… Read More >
A Letter From Our CEO for Regenerative Medicine
Aug 16, 2023
Tyler Barrett has served as Chief Executive Officer of Regenative Labs for the past three years. With extensive experience as… Read More >
Regenative Labs: Wharton’s Jelly Study on TMJ Defects
Jun 02, 2023
PENSACOLA, Fla., May 30, 2023 /PRNewswire/ — Regenative Labs (Regenative), a leading HCT/P manufacturer, announces one of its observational study… Read More >
Regenative Labs & Dr. Michael Lavor: Charcot Foot Study
Apr 24, 2023
Study approved by institutional review board of the Institute of Regenerative and Cellular Medicine. April 24, 2023—Regenative Labs (Regenative), a… Read More >
Regenative Labs Presents Wharton’s Jelly Studies at Wound Care Symposium
Apr 10, 2023
April 10, 2023, Pensacola, FL— Regenative Labs (Regenative), a leading provider of regenerative medicine solutions, announced that it will present… Read More >
Regenative Labs Updates Wharton’s Jelly Knee Study
Feb 20, 2023
New data demonstrates statistically significant reported WOMAC improvement. February 20, 2023, Pensacola, FL – Regenative Labs (Regenative), a leading HCT/P… Read More >
Regenative Labs & Dr. Albert Lai: Wharton’s Jelly in Si Joint Care
Jan 19, 2023
January 19, 2023. Pensacola, FL— Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective analysis of patients who have… Read More >